Grants and Contracts per year
Search results
-
Active
A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel with or without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Newly Diagnosed Subjects with Previously Untreated Stages III or IV High-Grade Serious Epithelial Ovarian,
Ueland, F., Baldwin Branch, L., Desimone, C. & Miller, R.
Gynecological Oncology Group Foundation Incorporated
12/23/15 → 7/4/24
Project: Research project